| Feb 4, 2026 |
Feb 5, 2026 |
Combs Andrew
|
Chief Chemistry Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2026 |
Feb 5, 2026 |
Scherle Peggy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2026 |
Feb 5, 2026 |
Lim Bryant David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2026 |
Feb 5, 2026 |
Vaddi Krishna
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 17, 2025 |
Oct 20, 2025 |
Dorton Katina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 20, 2025 |
Dorton Katina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 4, 2025 |
Oct 7, 2025 |
Huang Jane
|
President |
Sell |
47.5
|
-3,355
|
-3.72%
|
✗
|
$4.9K |
| Jul 4, 2025 |
Jul 8, 2025 |
Huang Jane
|
President |
Sell |
47.5
|
-3,355
|
-3.98%
|
✗
|
$2.7K |
| Jun 12, 2025 |
Jun 13, 2025 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 13, 2025 |
Scherer Paul C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Dier Mardi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
FRIEDMAN PAUL A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Bonita David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2025 |
Apr 7, 2025 |
Huang Jane
|
President |
Sell |
47.5
|
-3,355
|
-4.29%
|
✗
|
$2.3K |
| Mar 25, 2025 |
Mar 27, 2025 |
Combs Andrew
|
Chief Chemistry Officer |
Buy |
95.0
|
+100,000
|
26.31%
|
✗
|
$69.3K |
| Mar 25, 2025 |
Mar 27, 2025 |
Vaddi Krishna
|
CEO |
Buy |
97.5
|
+675,000
|
22.54%
|
✗
|
$467.4K |
| Mar 20, 2025 |
Mar 24, 2025 |
Vaddi Krishna
|
CEO |
Buy |
68.8
|
+20,416
|
0.69%
|
✗
|
$14.9K |
| Mar 14, 2025 |
Mar 18, 2025 |
Vaddi Krishna
|
CEO |
Buy |
78.8
|
+39,105
|
1.33%
|
✗
|
$29.5K |
| Mar 12, 2025 |
Mar 14, 2025 |
Vaddi Krishna
|
CEO |
Buy |
87.5
|
+97,500
|
3.44%
|
✗
|
$69.6K |
| Feb 4, 2025 |
Feb 5, 2025 |
Lim Bryant David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2025 |
Feb 5, 2025 |
Scherle Peggy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2025 |
Feb 5, 2025 |
Combs Andrew
|
Chief Chemistry Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2025 |
Feb 5, 2025 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2025 |
Feb 5, 2025 |
Vaddi Krishna
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 4, 2025 |
Jan 7, 2025 |
Huang Jane
|
President |
Sell |
47.5
|
-3,859
|
-5.31%
|
✗
|
$5.4K |
| Dec 31, 2024 |
Jan 3, 2025 |
Vaddi Krishna
|
CEO |
Buy |
55.0
|
+5,000
|
0.18%
|
✗
|
$6K |
| Dec 30, 2024 |
Jan 2, 2025 |
Vaddi Krishna
|
CEO |
Buy |
61.3
|
+10,000
|
0.35%
|
✗
|
$12K |
| Dec 20, 2024 |
Dec 26, 2024 |
Combs Andrew
|
Chief Chemistry Officer |
Buy |
95.0
|
+63,075
|
20.05%
|
✗
|
$85.5K |
| Dec 19, 2024 |
Dec 20, 2024 |
Lim Bryant David
|
CFO |
Buy |
91.3
|
+25,000
|
1041.67%
|
✗
|
$22.6K |
| Dec 18, 2024 |
Dec 20, 2024 |
Vaddi Krishna
|
CEO |
Buy |
87.5
|
+106,888
|
3.94%
|
✗
|
$99.3K |
| Oct 4, 2024 |
Oct 7, 2024 |
Huang Jane
|
President |
Sell |
47.5
|
-3,349
|
-5.02%
|
✗
|
$6.7K |
| Jul 4, 2024 |
Jul 8, 2024 |
Huang Jane
|
President |
Sell |
46.3
|
-3,347
|
-5.52%
|
✗
|
$12K |
| Jun 14, 2024 |
Jun 18, 2024 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 18, 2024 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 18, 2024 |
FRIEDMAN PAUL A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 18, 2024 |
Dier Mardi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 18, 2024 |
Bonita David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 18, 2024 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 14, 2024 |
May 16, 2024 |
Lim Bryant David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2024 |
Apr 8, 2024 |
Huang Jane
|
President |
Sell |
46.3
|
-3,347
|
-6.13%
|
✗
|
$15.9K |
| Mar 1, 2024 |
Mar 4, 2024 |
Lim Bryant David
|
Chief Legal Officer, Corp Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 4, 2024 |
Scherle Peggy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 4, 2024 |
Combs Andrew
|
Chief Chemistry Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 4, 2024 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 4, 2024 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 4, 2024 |
Vaddi Krishna
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 4, 2024 |
Jan 8, 2024 |
Huang Jane
|
President |
Sell |
46.3
|
-3,844
|
-7.83%
|
✗
|
$14.5K |
| Dec 13, 2023 |
Dec 13, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 4, 2023 |
Oct 6, 2023 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 4, 2023 |
Jul 6, 2023 |
Huang Jane
|
President |
Sell |
46.3
|
-3,242
|
-9.65%
|
✗
|
$15.1K |
| Jun 16, 2023 |
Jun 21, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2023 |
Jun 21, 2023 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2023 |
Jun 21, 2023 |
FRIEDMAN PAUL A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2023 |
Jun 21, 2023 |
Dier Mardi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2023 |
Jun 21, 2023 |
Bonita David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2023 |
Jun 21, 2023 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2023 |
May 26, 2023 |
Vaddi Krishna
|
CEO |
Buy |
55.0
|
+1,900
|
0.07%
|
✗
|
$9.8K |
| May 24, 2023 |
May 25, 2023 |
Lim Bryant David
|
Chief Legal Officer, Corp Sec. |
Buy |
91.3
|
+2,400
|
100.00%
|
✗
|
$12.9K |
| May 23, 2023 |
May 25, 2023 |
Chardonnet Laurent
|
CFO |
Buy |
91.3
|
+5,000
|
13.45%
|
✗
|
$27.5K |
| May 23, 2023 |
May 25, 2023 |
Vaddi Krishna
|
CEO |
Buy |
65.0
|
+11,856
|
0.44%
|
✗
|
$66.7K |
| May 22, 2023 |
May 24, 2023 |
ORBIMED ADVISORS LLC
|
Director |
Buy |
95.0
|
+869,565
|
9.40%
|
✗
|
$5M |
| May 22, 2023 |
May 24, 2023 |
Bonita David P
|
Director |
Buy |
95.0
|
+869,565
|
9.40%
|
✗
|
$5M |
| May 22, 2023 |
May 24, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2023 |
Apr 6, 2023 |
Huang Jane
|
President |
Sell |
22.5
|
-13,280
|
-35.41%
|
✗
|
$81.3K |
| Mar 1, 2023 |
Mar 2, 2023 |
Lim Bryant David
|
Chief Legal Officer, Corp Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 22, 2023 |
Lim Bryant David
|
Chief Legal Counsel, Corp Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2023 |
Feb 9, 2023 |
Scherle Peggy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2023 |
Feb 9, 2023 |
Combs Andrew
|
EVP, Head of Chemistry |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2023 |
Feb 9, 2023 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2023 |
Feb 9, 2023 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2023 |
Feb 9, 2023 |
Vaddi Krishna
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 21, 2022 |
Dec 22, 2022 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 20, 2022 |
Dec 21, 2022 |
Vaddi Krishna
|
CEO |
Buy |
72.5
|
+19,188
|
0.72%
|
✗
|
$98.4K |
| Dec 8, 2022 |
Dec 12, 2022 |
Chardonnet Laurent
|
CFO |
Buy |
91.3
|
+10,000
|
38.65%
|
✗
|
$47.6K |
| Jun 17, 2022 |
Jun 22, 2022 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2022 |
Jun 22, 2022 |
FRIEDMAN PAUL A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2022 |
Jun 22, 2022 |
Dier Mardi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2022 |
Jun 22, 2022 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2022 |
Jun 22, 2022 |
Bonita David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2022 |
Jun 22, 2022 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 1, 2022 |
Jun 1, 2022 |
Chardonnet Laurent
|
CFO |
Buy |
91.3
|
+10,000
|
68.97%
|
✗
|
$42.3K |
| May 2, 2022 |
May 4, 2022 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 6, 2022 |
Huang Jane
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2022 |
Apr 4, 2022 |
Combs Andrew
|
EVP, Head of Chemistry |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 21, 2022 |
Mar 22, 2022 |
Chardonnet Laurent
|
CFO |
Neutral |
90.0
|
+6,500
|
81.25%
|
✗
|
- |
| Feb 15, 2022 |
Feb 17, 2022 |
Scherle Peggy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2022 |
Feb 17, 2022 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2022 |
Feb 17, 2022 |
Vaddi Krishna
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2022 |
Feb 17, 2022 |
Morosini Deborah
|
EVP, Chief of Clinical Affairs |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2022 |
Feb 17, 2022 |
Combs Andrew
|
EVP, Head of Chemistry |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
Sandor Victor
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 15, 2021 |
Dec 17, 2021 |
Morosini Deborah
|
EVP, Chief of Clinical Affairs |
Sell |
7.5
|
-28,751
|
-98.48%
|
✓
|
$373.8K |
| Dec 13, 2021 |
Dec 15, 2021 |
Combs Andrew
|
EVP, Head of Chemistry |
Buy |
87.5
|
+8,000
|
3.07%
|
✗
|
$94.9K |
| Dec 13, 2021 |
Dec 14, 2021 |
Chardonnet Laurent
|
CFO |
Neutral |
90.0
|
+5,000
|
166.67%
|
✗
|
- |
| Dec 13, 2021 |
Dec 14, 2021 |
Vaddi Krishna
|
CEO |
Neutral |
60.0
|
+8,000
|
0.31%
|
✗
|
- |
| Nov 29, 2021 |
Dec 1, 2021 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 1, 2021 |
Chardonnet Laurent
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |